Thyroid Cancer Tumor Board Panel Discussion

This session will review recent advances in managing thyroid cancer. The discussion will include the appropriate surgical intervention in patients with thyroid cancer and controversy regarding (radioactive iodine therapy) RAI vs. active surveillance in patients with ATA intermediate risk of recurrence. This session will also address the prognostic implications of different mutations in patients with thyroid cancer and indications for referral to a medical oncology/ thyroid cancer center.

Thyroid Cancer Tumor Board Panel Discussion

Peter Sadow, MD, PhD

Massachusetts General Hospital & Harvard Medical School

Thyroid Cancer Tumor Board Panel Discussion

Michael Tuttle, MD

Memorial Sloan Kettering Cancer Center.

Thyroid Cancer Tumor Board Panel Discussion

Tracy Wang, MD, MPH, FACS, FSSO, DABS

Medical College of Wisconsin

Thyroid Cancer Tumor Board Panel Discussion

Lori Wirth, MD

Harvard Medical School

Thyroid Cancer Tumor Board Panel Discussion

Sara Ahmadi, MD

Brigham and Women's Hospital